Delivery Order SPE2DB20D1109-SPE2DB25FP71U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $4,554.55 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector units. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside provisions, reflecting the competitive nature of the procurement. AmerisourceBergen Drug Corp, a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract carries a ceiling value of $7,564.38 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. This award represents a non-set-aside competitive procurement and is performed at the vendor's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,189.39 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of the specialty medication AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. This contract, which does not have a set-aside designation, has an ultimate completion date of December 10, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company maintains significant Indefinite...
- The Defense Logistics Agency awarded a $348,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AJOVY 225 MG/1.5 ML autoinjectors. The single-award contract supports DLA's medical supply needs and calls for Amerisourcebergen to deliver 1.5mL autoinjectors of AJOVY, a medication used to prevent migraines, to a location in Conshohocken, Pennsylvania by July 14, 2023. No subcontractors or set-aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector medication, valued at $1,300.58. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under the company's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred forty-eight thousand three hundred thirty-two dollars ($348,332) to Amerisourcebergen Drug Corporation for the supply of two hundred twenty-five milligrams per one and a half milliliters doses of AJOVY autoinjectors. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania from September 18 through September 19, 2023. The award was made using the Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.91 firm fixed-price delivery order is for the supply of 225 mg/1.5 ml AJOVY auto-injector products. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The contract has a potential value of $1,055.52 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is one of multiple delivery orders issued...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP71UDelivery Order
The Defense Logistics Agency awarded a $1,092.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on September 9, 2025, with an ultimate completion date of September 10, 2025. AJOVY is a prescription medication used for chronic weight management. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, the company leverages its comprehensive IDC vehicle to provide a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The firm's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/9/25 |